Researchers have identified a small molecule that may help treat people with epilepsy whose condition has become resistant to the benzodiazepine drugs usually used in managing seizures. The research, conducted in laboratory cells and rodents, was published in Cell Reports Medicine.
Uncontrolled epilepsy can lead to frequent and prolonged seizures lasting five minutes or more that can cause brain cell damage and even death. The condition affects an estimated 3.4 million people in the U.S. and millions more worldwide.
Epilepsy occurs when the intricate, delicate balance of signaling by neurons in the brain malfunctions, causing neurons to fire too much and trigger seizures. Benzodiazepines slow down the messages traveling between neurons.
“While seizures can frequently be controlled with medications, up to 30 percent of those with epilepsy develop drug resistance after a period of time,” says study co-first author.
The scientists were looking for targets in the brain that could restore normal signaling. They focused on a potassium chloride co-transporter called KCC2. In the normal brain, KCC2 helps pump chloride out of nerve cells, which helps brake neuronal overfiring.
“Previous research in both rodents and humans had shown that low KCC2 levels and activity in the brain is linked to drug-resistant and prolonged seizures,” explains a co-first author.
The collaborators screened more than one million compounds to identify a family of compounds that might be able to affect the activity of KCC2 in the brain.
The scientists tested one of the compounds in that family – Compound 350 – and observed that in combination with benzodiazepine, the Compound 350 reduced seizure activity in rodents with drug-resistant seizures.
“We also observed that mice treated with the benzodiazepine and Compound 350 had lower cell death in the brain than those treated only with the benzodiazepine,” said the author, adding that this was most likely because rodents treated with both drugs were not having as many seizures.
“The small molecules we have identified have the capacity to be developed as first-in-class drugs to alleviate drug-resistant epilepsies and neurodegenerative disorders,” says the uathor. “In collaboration with Ovid Therapeutics, these compounds are now under clinical development.”
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(23)00049-6
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fdirect-activation-of&filter=22
Activating potassium-chloride co-transporter to treat epilepsy
- 504 views
- Added
Latest News
Humans can intermittently r…
By newseditor
Posted 04 Dec
Why young kids don't get se…
By newseditor
Posted 04 Dec
Phosphatidylinositol 3,5-bi…
By newseditor
Posted 04 Dec
Probiotic-guided CAR-T cell…
By newseditor
Posted 04 Dec
Cell atlases of the human b…
By newseditor
Posted 04 Dec
Other Top Stories
Genes that drive ovarian cancer identified!
Read more
Neural Differentiation Defect from Loss of a Single Gene Fuels Dead…
Read more
How a protein mutation leads to colorectal cancer
Read more
Role of lipids in leukemia relapse
Read more
PARP enzymes bring broken DNA together
Read more
Protocols
Cheap, cost-effective, and…
By newseditor
Posted 03 Dec
Temporally multiplexed imag…
By newseditor
Posted 02 Dec
Efficient elimination of ME…
By newseditor
Posted 01 Dec
Personalized drug screening…
By newseditor
Posted 30 Nov
Multi-chamber cardioids unr…
By newseditor
Posted 29 Nov
Publications
Behavioral and brain respon…
By newseditor
Posted 04 Dec
Toward low-cost gene therap…
By newseditor
Posted 04 Dec
The bidirectional immune cr…
By newseditor
Posted 04 Dec
Leveraging human immune org…
By newseditor
Posted 04 Dec
Single-cell long-read seque…
By newseditor
Posted 04 Dec
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar